BMI View: Increased longevity in developed markets translates into an increased demand for care for theelderly, healthcare services and medicines. However, despite increased life expectancy, in emergingmarkets such as Gabon communicable diseases will remain a significant health burden over the next twodecades. This will continue to limit revenue-earning opportunities for companies whose product portfolioscontain treatments for long-term diseases.Headline Expenditure Forecasts? Pharmaceuticals: XAF67.65bn (US$136mn) in 2012 to XAF72.45bn (US$148mn) in 2013; +7.1% inlocal currency and 9.0% in US dollar terms.? Healthcare: XAF278.54bn (US$559mn) in 2012 to XAF2...
No comments:
Post a Comment